ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Cell Cycle >Aurora Kinase Inhibitors >GSK1070916
GSK1070916
- CAS No.
- 942918-07-2
- Chemical Name:
- GSK1070916
- Synonyms
- CS-364;GSK1070916;GSK-1070916A;GSK1070916 USP/EP/BP;GSK-1070916 (NMI-900);GSK1070916;GSK 1070916;GSK-1070916?( GSK-1070916A);GSK1070916;GSK-1070916;GSK 1070916;GSK1070916 (NMI900 or GSK1070916 A);GSK-1070916 GSK1070916 NMI-900 NMI900
- CBNumber:
- CB42485003
- Molecular Formula:
- C30H33N7O
- Molecular Weight:
- 507.63
- MOL File:
- 942918-07-2.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:08
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302-H315-H319-H335 | |||||||||
Precautionary statements | P261-P305+P351+P338 | |||||||||
NFPA 704 |
|
GSK1070916 Preparation Products And Raw materials
Raw materials
Preparation Products
GSK1070916 Suppliers
Global( 105)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 32760 | 60 | Inquiry |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | China | 49391 | 58 | Inquiry |
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | China | 26368 | 58 | Inquiry |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | China | 10522 | 58 | Inquiry |
InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6393 | 58 | Inquiry |
TargetMol Chemicals Inc. | +1-781-999-5354 | United States | 19973 | 58 | Inquiry |
ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | China | 11681 | 58 | Inquiry |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | China | 8474 | 58 | Inquiry |
Aladdin Scientific | +1-+1(833)-552-7181 | United States | 57511 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
942918-07-2(GSK1070916)Related Search:
chevron_left
1of2
chevron_right
N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea
GSK1070916
3-(4-(4-(2-(3-((Dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea
N'-[4-[4-[2-[3-[(DiMethylaMino)Methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl
GSK-1070916A
GSK1070916;GSK 1070916
CS-364
GSK1070916;GSK-1070916;GSK 1070916
Urea, N'-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethyl-
GSK1070916 USP/EP/BP
GSK1070916 (NMI900 or GSK1070916 A)
GSK-1070916 GSK1070916 NMI-900 NMI900
GSK-1070916?( GSK-1070916A)
GSK-1070916 (NMI-900)
942918-07-2
Inhibitors
Inhibitor